, February 26, 2018 ) North America Electrophoresis Market was worth USD 771.4 million in 2017 and estimated to be growing at a CAGR of 5.05%, to reach USD 986.87 million by 2022. Electrophoresis is the motion of dispersed particles relative to a fluid influenced under a uniform electric field applied spatially.
Electrophoresis is used as immunoelectrophoresis which can be used to detect specific proteins like immunoglobulins which act as antibodies. These are part of body’s immune system and protect from foreign proteins. Analyzing these antibodies helps design new therapies to treat these threats and provides insight into conditions like allergies and autoimmune disorders.
View full report @ http://www.marketdataforecast.com/market-reports/north-america-electrophoresis-market-2977/
The primary factors
accounted for the growth of market are rising funding for electrophoresis techniques, rising incidences of chronic diseases, cancer and genetic disorders, growing focus on next generation sequencing (NGS). Growing number of industry-academia research collaborations and growing funding for research on genomic and proteomic techniques will also support in growth of the market. On the other hand, electrophoresis techniques are time consuming operations and offer limited sample analysis and presence of alternative technologies to electrophoresis may curb the growth of market.
The North America market for Electrophoresis is segmented based on Product, Application and End Users. Based on Product – Gel Electrophoresis, Capillary Electrophoresis, Reagents, Geldoc and Imaging. Gel electrophoresis is further segmented to vertical and horizontal electrophoresis, Vertical is further segmented based on gel type as Agarose and Polyacrylamide. Based on Application – Diagnostic, Research, Quality Control. Based on End Users – Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers. Based on Geographical analysis the market is separated into regions of United States of America and Canada. USA is leading the market while Canada is at second place. Growing focus of stakeholders on research projects involving proteins, associated biomolecules and genes has helped USA dominate the market. USA is also expected to grow the fastest due to increasing research funding, growing proteomics and genomics techniques and rising adoption of advanced electrophoresis techniques. Reagents holds the major share in the market in terms of products while gel electrophoresis is expected to grow the fastest and academic and research institutes hold major share in terms of end users. Hospitals and diagnostic centers are expected to grow the fastest.
Get Free Sample Report @ http://www.marketdataforecast.com/market-reports/north-america-electrophoresis-market-2977/request-sample
Some of the key players dominating this market include Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Merck Millipore, PerkinElmer, QIAGEN N.V., Lonza Group Ltd., Shimadzu Corporation, Harvard Bioscience, Sebia Group and C.B.S. Scientific Company.
About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
More about Market Data Forecast
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast